QHREDGS Enhances Tube Formation, Metabolism and Survival of Endothelial Cells in Collagen-Chitosan Hydrogels

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Miklas, Jason W ^a   Dallabrida, Susan M ^b   Reis, Lewis A ^a   Ismail, Nesreen ^b   Rupnick, Maria ^c,d   Radisic, Milica ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHAVBETA1 INTEGRIN; ANGIOPOIETIN 1; CHITOSAN; COLLAGEN; FIBRIN; INTEGRIN; NITROUS OXIDE; PACLITAXEL; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL ENCAPSULATION; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN CELL; HYDROGEL; PROTEIN DOMAIN; TISSUE ENGINEERING;

ADENOSINE TRIPHOSPHATE; ANGIOPOIETIN-1; CELL SURVIVAL; CELLS, CULTURED; CELLS, IMMOBILIZED; CHITOSAN; COLLAGEN; ENDOTHELIAL CELLS; HUMANS; HYDROGELS; INTEGRIN ALPHA5BETA1; INTEGRIN ALPHAVBETA3; PEPTIDES;

EID: 84883183769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072956     Document Type: Article

References (55)

1. Rustad KC, Sorkin M, Levi B, Longaker MT, Gurtner GC, (2010) Strategies for organ level tissue engineering. Organogenesis 6: 151-157.
2. Khan OF, Sefton MV, (2011) Endothelialized biomaterials for tissue engineering applications in vivo. Trends in biotechnology 29: 379-387.
3. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, et al. (2006) Engineering complex tissues. Tissue engineering 12: 3307-3339.
4. Lee K, Silva EA, Mooney DJ, (2011) Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. Journal of the Royal Society, Interface/the Royal Society 8: 153-170.
5. Chiu LL, Radisic M, (2010) Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 31: 226-241.
6. Chiu LL, Radisic M, Vunjak-Novakovic G, (2010) Bioactive scaffolds for engineering vascularized cardiac tissues. Macromolecular bioscience 10: 1286-1301.
7. Phelps EA, Landazuri N, Thule PM, Taylor WR, Garcia AJ, (2010) Bioartificial matrices for therapeutic vascularization. Proceedings of the National Academy of Sciences of the United States of America 107: 3323-3328.
8. Place ES, Evans ND, Stevens MM, (2009) Complexity in biomaterials for tissue engineering. Nature materials 8: 457-470.
9. Dallabrida SM, Ismail N, Oberle JR, Himes BE, Rupnick MA, (2005) Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circulation research 96: e8-24.
10. Rask F, Dallabrida SM, Ismail NS, Amoozgar Z, Yeo Y, et al. (2010) Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. Journal of biomedical materials research Part A 95: 105-117.
11. Reis LA, Chiu LL, Liang Y, Hyunh K, Momen A, et al. (2012) A peptide-modified chitosan-collagen hydrogel for cardiac cell culture and delivery. Acta biomaterialia 8: 1022-1036.
12. Tinsley JH, De Lanerolle P, Wilson E, Ma W, Yuan SY, (2000) Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability. American journal of physiology Cell physiology 279: C1285-1289.
13. Hanjaya-Putra D, Bose V, Shen YI, Yee J, Khetan S, et al. (2011) Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 118: 804-815.
14. Mochizuki N, (2009) Vascular integrity mediated by vascular endothelial cadherin and regulated by sphingosine 1-phosphate and angiopoietin-1. Circulation journal: official journal of the Japanese Circulation Society 73: 2183-2191.
15. van der Heijden M, van Nieuw Amerongen GP, van Bezu J, Paul MA, Groeneveld AB, et al. (2011) Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells. PloS one 6: e23448.
16. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W, (1998) Angiopoietin-1 induces sprouting angiogenesis in vitro. Current biology: CB 8: 529-532.
17. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, et al. (2007) Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. The Journal of biological chemistry 282: 23910-23918.
18. Cascone I, Napione L, Maniero F, Serini G, Bussolino F, (2005) Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. The Journal of cell biology 170: 993-1004.
19. Camenisch G, Pisabarro MT, Sherman D, Kowalski J, Nagel M, et al. (2002) ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. The Journal of biological chemistry 277: 17281-17290.
20. Hersel U, Dahmen C, Kessler H, (2003) RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24: 4385-4415.
21. Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, et al. (2004) COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proceedings of the National Academy of Sciences of the United States of America 101: 5547-5552.
22. Holland J, Hersh L, Bryhan M, Onyiriuka E, Ziegler L, (1996) Culture of human vascular endothelial cells on an RGD-containing synthetic peptide attached to a starch-coated polystyrene surface: comparison with fibronectin-coated tissue grade polystyrene. Biomaterials 17: 2147-2156.
23. Sagnella S, Anderson E, Sanabria N, Marchant RE, Kottke-Marchant K, (2005) Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin. Tissue engineering 11: 226-236.
24. Sagnella SM, Kligman F, Anderson EH, King JE, Murugesan G, et al. (2004) Human microvascular endothelial cell growth and migration on biomimetic surfactant polymers. Biomaterials 25: 1249-1259.
25. Wang X, Heath DE, Cooper SL, (2012) Endothelial cell adhesion and proliferation to PEGylated polymers with covalently linked RGD peptides. Journal of biomedical materials research Part A 100: 794-801.
26. Van Slyke P, Alami J, Martin D, Kuliszewski M, Leong-Poi H, et al. (2009) Acceleration of diabetic wound healing by an angiopoietin peptide mimetic. Tissue engineering Part A 15: 1269-1280.
27. Cho CH, Kammerer RA, Lee HJ, Yasunaga K, Kim KT, et al. (2004) Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proceedings of the National Academy of Sciences of the United States of America 101: 5553-5558.
28. Cho CH, Kim KE, Byun J, Jang HS, Kim DK, et al. (2005) Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circulation research 97: 86-94.
29. Augustin HG, Koh GY, Thurston G, Alitalo K, (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nature reviews Molecular cell biology 10: 165-177.
30. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, et al. (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nature cell biology 10: 513-526.
31. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nature cell biology 10: 527-537.
32. Fachinger G, Deutsch U, Risau W, (1999) Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18: 5948-5953.
33. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, et al. (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. The Journal of biological chemistry 275: 9102-9105.
34. Gavard J, Patel V, Gutkind JS, (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Developmental cell 14: 25-36.
35. Bredt DS, Snyder SH, (1994) Nitric oxide: a physiologic messenger molecule. Annual review of biochemistry 63: 175-195.
36. Harrison DG, (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. The Journal of clinical investigation 100: 2153-2157.
37. Noll G, Luscher TF, (1998) The endothelium in acute coronary syndromes. European heart journal 19Suppl C: C30-38.
38. DeBusk LM, Hallahan DE, Lin PC, (2004) Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Experimental cell research 298: 167-177.
39. Rask F, Mihic A, Reis L, Dallabrida SM, Ismail NS, et al. (2010) Hydrogels modified with QHREDGS peptide support cardiomyocyte survival in vitro and after sub-cutaneous implantation. Soft Matter 6: 5089-5099.
40. Ismail NS, Pravda EA, Li D, Shih SC, Dallabrida SM, (2010) Angiopoietin-1 reduces H(2)O(2)-induced increases in reactive oxygen species and oxidative damage to skin cells. The Journal of investigative dermatology 130: 1307-1317.
41. Oubaha M, Gratton JP, (2009) Phosphorylation of endothelial nitric oxide synthase by atypical PKC zeta contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro. Blood 114: 3343-3351.
42. Ilan N, Madri JA, (2003) PECAM-1: old friend, new partners. Current opinion in cell biology 15: 515-524.
43. Newman PJ, Newman DK, (2003) Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arteriosclerosis, thrombosis, and vascular biology 23: 953-964.
44. David S, Ghosh CC, Mukherjee A, Parikh SM, (2011) Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense. Arteriosclerosis, thrombosis, and vascular biology 31: 2643-2652.
45. Kwak HJ, So JN, Lee SJ, Kim I, Koh GY, (1999) Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS letters 448: 249-253.
46. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, et al. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circulation research 86: 24-29.
47. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M, Morla AO, (2001) Direct cell adhesion to the angiopoietins mediated by integrins. The Journal of biological chemistry 276: 26516-26525.
48. Davis GE, Koh W, Stratman AN, (2007) Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Birth defects research Part C, Embryo today: reviews 81: 270-285.
49. Bayless KJ, Salazar R, Davis GE, (2000) RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. The American journal of pathology 156: 1673-1683.
50. Folkman J, Klagsbrun M, (1987) Angiogenic factors. Science 235: 442-447.
51. Coultas L, Chawengsaksophak K, Rossant J, (2005) Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
52. Topper JN, Gimbrone MA Jr, (1999) Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Molecular medicine today 5: 40-46.
53. Davis GE, Camarillo CW, (1996) An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Experimental cell research 224: 39-51.
54. Zhang C, Hekmatfer S, Karuri NW (2013) A comparative study of polyethylene glycol hydrogels derivatized with the RGD peptide and the cell-binding domain of fibronectin. Journal of biomedical materials research Part A.
55. Guarnieri D, De Capua A, Ventre M, Borzacchiello A, Pedone C, et al. (2010) Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters. Acta biomaterialia 6: 2532-2539.